Characterization of Cysteinyl Leukotriene Receptors on Human Saphenous Veins: Antagonist Activity of Montelukast and its Metabolites

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  2004-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00005344-200401000-00017PMID 14668576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The ACh‐induced contraction in rat aortas is mediated by the Cys Lt1 receptor via intracellular calcium mobilization in smooth muscle cells

  2003cited by this paper
• Pharmacological evidence for a novel cysteinyl‐leukotriene receptor subtype in human pulmonary artery smooth muscle

  2002cited by this paper
• Changes in the Expression of Tachykinin Receptors in the Rat Uterus During the Course of Pregnancy1

  2001cited by this paper
• Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells.

  2001influential reference
• Efficiency of homocysteine plus copper in inducing apoptosis is inversely proportional to γ‐glutamyl transpeptidase activity

  2001cited by this paper
• An alternative pathway for metabolism of leukotriene D4: effects on contractions to cysteinyl‐leukotrienes in the guinea‐pig trachea

  2001influential reference
• Characterization of the Human Cysteinyl Leukotriene 2 Receptor*

  2000cited by this paper
• The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor.

  2000cited by this paper
• Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition.

  2000cited by this paper
• Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist.

  2000cited by this paper
• Functional studies of leukotriene receptors in vascular tissues.

  2000cited by this paper
• Functional expression and biophysical properties of polymorphic variants of the human gap junction protein connexin37.

  2000cited by this paper
• Leukotrienes in cardiovascular diseases.

  2000cited by this paper
• The Molecular Characterization and Tissue Distribution of the Human Cysteinyl Leukotriene CysLT2 Receptor

  2000cited by this paper
• Venous stasis causes release of interleukin 1beta (IL-1beta), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFalpha) by monocyte-macrophage.

  2000cited by this paper
• Interactions between leukotrienes and other inflammatory mediators/modulators in the microvasculature.

  2000cited by this paper
• Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes.

  2000cited by this paper
• The histomorphologic changes at the saphenofemoral junction in varicosis of the greater saphenous vein.

  2000cited by this paper
• Venous stasis causes release of interleukin 1β (IL‐1β), interleukin 6 (IL‐6) and tumor necrosis factor alpha (TNFα) by monocyte‐macrophage

  2000cited by this paper
• Furosemide inhibits thromboxane A2-induced contraction in isolated human internal mammary artery and saphenous vein.

  2000cited by this paper
• Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.

  1999cited by this paper
• Characterization of the human cysteinyl leukotriene CysLT1 receptor

  1999cited by this paper
• Dendritic Cells in Venous Pathologies

  1999cited by this paper
• Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.

  1999cited by this paper
• Functional comparison of the human isolated femoral artery, internal mammary artery, gastroepiploic artery, and saphenous vein.

  1999cited by this paper
• Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.

  1999cited by this paper
• The induction of GSH synthesis by nanomolar concentrations of NO in endothelial cells: a role for gamma-glutamylcysteine synthetase and gamma-glutamyl transpeptidase.

  1999cited by this paper
• Treatment of asthma with drugs modifying the leukotriene pathway.

  1999cited by this paper
• The induction of GSH synthesis by nanomolar concentrations of NO in endothelial cells: a role for γ‐glutamylcysteine synthetase and γ‐glutamyl transpeptidase

  1999cited by this paper
• Differential leukotriene constrictor responses in human atherosclerotic coronary arteries.

  1998cited by this paper
• Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease.

  1997cited by this paper
• Pharmacokinetics, Bioavailability, and Safety of Montelukast Sodium (MK-0476) in Healthy Males and Females

  1996cited by this paper
• Cysteinyl leukotriene receptors in the human lung: what's new?

  1996cited by this paper
• Preferential Vasoconstriction to Cysteinyl Leukotrienes in the Human Saphenous Vein Compared With the Internal Mammary Artery: Implications for Graft Performance

  1994cited by this paper
• Effect of surgical preparation and arterialization on vasomotion of human saphenous vein.

  1994cited by this paper
• Enhanced excretion of urinary leukotriene E4 in coronary artery disease and after coronary artery bypass surgery

  1993cited by this paper
• A second cysteinyl leukotriene receptor in human lung.

  1992cited by this paper
• In vitro evaluation of endothelial and smooth muscle function of primary varicose veins.

  1992cited by this paper
• Effects of leukotrienes C4 and D4 on human isolated saphenous veins.

  1992cited by this paper
• A Pharmacologic Analysis of Drug-Receptor Interaction

  1987cited by this paper
• Effects of l‐serine borate on antagonism of leukotriene C4‐induced contractions of guinea‐pig trachea

  1987cited by this paper
• Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways.

  1987cited by this paper
• EFFECTS OF VARIOUS PHARMACOLOGICAL AGENTS ON ISOLATED HUMAN BRONCHIAL AND PULMONARY ARTERIAL AND VENOUS MUSCLE PREPARATIONS CONTRACTED BY LEUKOTRIENE D4

  1987cited by this paper
• Pharmacological evidence that human intralobar airways do not contain different receptors that mediate contractions to leukotriene C4 and leukotriene D4.

  1986cited by this paper
• Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns.

  1985cited by this paper
• Pharmacological evidence for a distinct leukotriene C4 receptor in guinea-pig trachea.

  1984cited by this paper
• Contraction of isolated airway smooth muscle by synthetic leukotrienes C4 and D4.

  1981cited by this paper

• Leukotriene receptors in GtoPdb v.2025.3

  2025cites this paper
• Leukotriene receptors in GtoPdb v.2023.1 Leukotriene receptors in GtoPdb v.2023.1

  2023cites this paper
• A review of non-prostanoid, eicosanoid receptors: expression, characterization, regulation, and mechanism of action

  2021cites this paper
• Could Lipoxins Represent a New Standard in Ischemic Stroke Treatment?

  2021cites this paper
• Leukotriene receptors (version 2020.3) in the IUPHAR/BPS Guide to Pharmacology Database

  2020cites this paper
• Leukotriene receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• The role of small airway disease in asthma

  2014cites this paper
• Eicosanoids and Their Drugs in Cardiovascular Diseases: Focus on Atherosclerosis and Stroke

  2013cites this paper
• An eicosanoid-centric view of atherothrombotic risk factors

  2012cites this paper
• Cysteinyl leukotriene signaling through perinuclear CysLT1 receptors on vascular smooth muscle cells transduces nuclear calcium signaling and alterations of gene expression

  2012cites this paper
• International Union of Basic and Clinical Pharmacology. LXXXIV: Leukotriene Receptor Nomenclature, Distribution, and Pathophysiological Functions

  2011cites this paper
• Synthesis of cysteinyl leukotrienes in human endothelial cells: subcellular localization and autocrine signaling through the CysLT2 receptor

  2011cites this paper
• Cysteinyl Leukotrienes and Their Receptors: Molecular and Functional Characteristics

  2010cites this paper
• Cysteinyl‐leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends

  2007cites this paper
• Leukotriene Receptors: Crucial Components in Vascular Inflammation

  2007influential citation
• Cysteinyl-Leukotriene Receptors and Cellular Signals

  2007cites this paper
• The quest for new cysteinyl-leukotriene and lipoxin receptors: recent clues.

  2004cites this paper